Abstract
It has been reported that the β3-adrenergic receptor gene (ADRB3) is associated with abnormal metabolic risk factors. Therefore, we examined whether the Trp64Arg polymorphism of ADRB3 affects the occurrence of metabolic syndrome (MS). The participants were 2,395 subjects who underwent a medical examination in Shigaraki in Shiga, Japan. Among them, 1,416 subjects who gave informed consent for genetic analysis and were not receiving treatment for hypertension, diabetes, or hyperlipidemia were enrolled in this study. MS was diagnosed in 86 (16.0%) of 537 men, and 8 (0.9%) of 879 women. There was no significant relationship between ADRB3 polymorphism and the frequency of MS. Multiple logistic regression analysis including smoking, sex, and age as confounding factors showed no interaction between MS and ADRB3 polymorphism (odds ratio: 0.94; 95% confidence interval: 0.59–1.49; p=0.78). Subjects were also analyzed according to differences in the number of abnormal metabolic risk factors. However, there was no significant relationship between ADRB3 polymorphism and the number of such factors. In conclusion, in a general sample, the frequency of MS was 16.0% in men, and 0.9% in women. There was no relationship between ADRB3 polymorphism and MS.
Similar content being viewed by others
Article PDF
References
Emorine LJ, Marullo S, Briend-Sutren MM, et al: Molecular characterization of the human β3 adrenergic receptor. Science 1989; 245: 1118–1121.
Spronsen AV, Nahmias C, Krief S, Briend-Sutren MM, Strosberg AD, Emorine LJ : The promoter and intron/exon structure of the human and mouse β3 adrenergic receptor genes. Eur J Biochem 1993; 213: 1117–1124.
Krief S, Lonnqvist F, Raimbault S, et al: Tissue distribution of β3 adrenergic receptor m-RNA in man. J Clin Invest 1993; 91: 344–349.
Walston J, Silver K, Bogardus C, et al: Time of onset of non–insulin-dependent diabetes mellitus and genetic variation in the β3 adrenergic-receptor gene. N Engl J Med 1995; 333: 343–347.
Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC : Association of a polymorphism in the β3 adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348–351.
Clement K, Vaisse C, Manning BS, et al: Genetic variation in the β3 adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352–354.
Kadowaki H, Yasuda K, Iwamoto K, et al: A mutation in the β3 adrenergic-receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555–560.
Rissanen J, Kuopusjarvi J, Pihlajamaki J, et al: The Trp64Arg polymorphism of the β3 adrenergic receptor gene. Diabetes Care 1997; 20: 1319–1322.
Li LS, Lonnqvist F, Luthman H, Arner P : Phenotypic characterization of the Trp64Arg polymorphism in the beta3 adrenergic receptor gene in normal weight and obese. Diabetologia 1996; 39: 857–860.
Urhammer SA, Clausen JO, Hansen T, Pedersen O : Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Diabetes 1996; 45: 1115–1120.
Tamaki S, Iwai N, Tsujita Y, Nakamura Y, Ohmichi N, Kinoshita M : Variant of the β3-adrenegic receptor gene and coronary atherosclerosis in Japanese subjects. Int J Cardiol 1999; 69: 309–311.
Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM : The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153–3159.
Sattar N, Gaw A, Scherbakova O, et al: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414–419.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults : Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
The Examination Committee of Criteria for Metabolic Syndrome: Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 2005; 94: 794–809 ( in Japanese).
Tamaki S, Nakamura Y, Yoshino T, et al: The association between morning hypertension and metabolic syndrome in hypertensive patients. Hypertens Res 2006; 29: 783–788.
Nakamura Y, Amamoto K, Tamaki S, et al: Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels. Atherosclerosis 2002; 164: 171–177.
Amamoto K, Okamura T, Tamaki S, et al: Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population. Hypertens Res 2002; 25: 857–864.
Tamaki S, Nakamura Y, Tsujita Y, et al: Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertens Res 2002; 25: 843–848.
Tamaki S, Nakamura Y, Tabara Y, et al: Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effect on hypertension in a Japanese population (the Shigaraki Study). Hypertens Res 2005; 28: 645–650.
Tsujita Y, Nakamura Y, Zhang Q, et al: The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis ( in press).
Ozawa T, Ito M, Tamaki S, et al: Gender and age effects on ventricular repolarization abnormality in Japanese general carriers of a G643S common single nucleotide polymorphism for the KCNQ1 gene. Circ J 2006; 70: 645–650.
Myers GL, Cooper GR, Henderson LO, Hassemer DJ, Kimberly MM : Standardization of lipid and lipoprotein measurement, in Rifai N, Warnick GR, Dominiczak MH ( eds): Handbook of Lipoprotein Testing. Washington, DC, AACC, 1997, pp 223–250.
Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M : Mutation of β3 adrenergic receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433–1434.
Yuan X, Yamada K, Koyama K, et al: Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract 1997; 37: 1–7.
Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML : Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 28: 3429–3434.
Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD : Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 1996; 6: 2638–2641.
Pietri-Rouxel F, Manning STJ, Gros J, Strosberg AD : The biochemical effect of the naturally occurring Trp64-Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 1997; 247: 1174–1179.
Kissebah AH, Sonnenberg GE, Myklebust J, et al: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000; 97: 14478–14483.
Castellano M, Muiesan ML, Cinelli A, et al: Lack of association of the Trp64Arg polymorphism of the β3 adrenergic-receptor gene with blood pressure. Circulation 1997; 96 ( Suppl 1): 226.
Fujisawa T, Ikegami H, Yamato E, et al: Trp64Arg mutation of beta3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 1997; 10: 101–105.
Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese men—the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203–208.
Tanaka H, Shimabukuro T, Shimabukuro M : High prevalence of metabolic syndrome among men in Okinawa. J Atheroscler Thromb 2005; 12: 284–288.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamaki, S., Nakamura, Y., Tabara, Y. et al. Relationship between Metabolic Syndrome and Trp64Arg Polymorphism of the β3-Adrenergic Receptor Gene in a General Sample: The Shigaraki Study. Hypertens Res 29, 891–896 (2006). https://doi.org/10.1291/hypres.29.891
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.891
Keywords
This article is cited by
-
ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1
Lipids in Health and Disease (2018)
-
Genetic Background, Adipocytokines, and Metabolic Disorders in Postmenopausal Overweight and Obese Women
Biochemical Genetics (2016)
-
Synopsis and Data Synthesis of Genetic Association Studies in Hypertension for the Adrenergic Receptor Family Genes: The CUMAGAS-HYPERT Database
American Journal of Hypertension (2010)
-
Génétique du syndrome métabolique
Bio tribune magazine (2009)
-
The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals
International Journal of Obesity (2008)
